In a period of market fluctuation, STERIS plc (NYSE:STE) has remained an interesting opportunity. Several large institutional investors such as SG Americas Securities LLC, Legal & General Group Plc, Holocene Advisors LP, Groupama Asset Management and others maintain firm investment positions in the company despite offloading by a few like Magnetar Financial LLC, Franklin Resources Inc., APG Asset Management N.V. among others. Notably, Vanguard reported no shares in its latest portfolio breakdown. STE stock also witnessed a 0.4% increase post the previous earnings report. The company's recent performance underlies analyst confidence, with a majority rating ranging from 'Buy' to 'Moderate Buy'. One dramatic update was Rep. Gilbert Ray Cisneros, Jr. and Rep. April McClain Delaney purchasing shares. Q3 2026 earnings call highlighted strong revenue growth and improved margins despite tariff challenges. The firm also recently increased its quarterly dividend by 10.5% to $0.63/share. With a current all-time high at 268.72 USD, STE remains an interesting prospect despite its underperformance compared to Nasdaq.
Steris Plc STE News Analytics from Thu, 07 Nov 2024 08:00:00 GMT to Sat, 28 Mar 2026 05:47:51 GMT - Rating 5 - Innovation 2 - Information 4 - Rumor 3
